TheraRadar
Clinical-Stage Companies / Biolab Sanus Farmaceutica

Biolab Sanus Farmaceutica

Pre-Approval PRO BETA
🟡

Slowing Activity

No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 3/1/2025

13
Total Trials
4
Phase 3
0
Phase 2
0
Recruiting
87
Score

Pipeline by Phase

Phase 3
4
Phase 2
Phase 1
9

Therapeutic Focus

Pharmacokinetics Healthy Subjects Tinea Pedis Healthy Healthy Volunteers

Clinical Trials (13)

NCT06564883 Phase 3 NOT YET RECRUITING

Hydration and Acceptability of the Genital and Skin Mucosa of a Vaginal Moisturizer in Menopausal Women

Started: 3/1/2025

NCT03320486 Phase 3 COMPLETED

Non-inferiority Trial of Dapaconazole Versus Ketoconazole

Started: 11/1/2017

NCT02606383 Phase 3 WITHDRAWN

Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis

Started: 6/1/2016

NCT00986570 Phase 3 COMPLETED

Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face

Started: 9/1/2009

NCT04729088 Phase 1 WITHDRAWN

Pharmacokinetics Trial of Isosorbide Mononitrate 0.5% Gel for Intra Anal Application in Healthy Subjects

Started: 12/20/2020

NCT02817750 Phase 1 COMPLETED

Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation

Started: 7/5/2017

NCT02814058 Phase 1 COMPLETED

Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 1.75 mg Formulation

Started: 7/5/2017

NCT02957435 Phase 1 WITHDRAWN

Pharmacokinetics Study of Eplerenone Coated Tablets

Started: 7/1/2017

NCT02667561 Phase 1 WITHDRAWN

Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%

Started: 7/1/2017

NCT02667535 Phase 1 WITHDRAWN

PK, PD and Safety Comparative Trial of Isosorbide Mononitrate Gel in Healthy Participants and With Anal Fissure

Started: 7/1/2017

NCT02632812 Phase 1 COMPLETED

Gastrointestinal Integrity After Naproxen + Rebamipide Versus Naproxen + Placebo

Started: 10/1/2014

NCT02607696 Phase 1 WITHDRAWN

Pharmacokinetics of Zolpidem Orodispersible Tablet

Started: 5/1/2016

NCT02607657 Phase 1 WITHDRAWN

Pharmacokinetics of Eplerenone Tablet

Started: 5/1/2016

Drug Candidates

Isosorbide mononitrate Dapaconazole Ketoconazole zolpidem hemitartarate tablet 3.5 mg (fasting + post-prandial) zolpidem hemitartarate tablet 3.5 mg (post-prandial + fasting) zolpidem hemitartarate 1.75 mg - Sequency 1 zolpidem hemitartarate 1.75 mg - Sequency 2 eplerenone Testosterone gel 1% 2.2 mg Testosterone gel 1% 4.4 mg
Activity Status: Slowing
Last Trial Started: 3/1/2025
Last Trial Ended: 11/12/2019
Trials (12 months): 0
Completed Trials: 5
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.